Example: Heart Attack

Search clinical trials for: Raclopride

Total 29 results

NCT02233829

Suspended

Dopamine Rhythms in Health and Addiction

Conditions: Cocaine Abuse
NCT03190954

Recruiting

Brain Dopaminergic Signaling in Opioid Use Disorders

Conditions: Normal Physiology; Opioid-Related Disorders
NCT02020408

Completed

Monoamine Contributions to Neurocircuitry in Eating Disorders

Conditions: Eating Disorder
NCT00832221

Completed

Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL

Conditions: Depression
NCT00032812

Completed

The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease

Conditions: Parkinson Disease; Healthy
NCT03026036

Recruiting

Neuroimaging Studies of Reward Processing in Depression

Conditions: Major Depressive Disorder
NCT03648892

Recruiting

Brain Dopamine Function in Human Obesity

Conditions: Obesity; Healthy Volunteers; Overweight
NCT03999190

Withdrawn

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

Conditions: Schizophrenia
NCT03637075

Recruiting

Raclopride-PET/MRT

Conditions: Diabetes Mellitus, Type 2
NCT00670293

Completed

Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa

Conditions: Eating Disorders
NCT00015301

Completed

Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Conditions: Cocaine-Related Disorders; Substance-Related Disorders
NCT00562198

Terminated

PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding

Conditions: Parkinson´s Disease
NCT02152670

Terminated

Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET

Conditions: Cocaine Dependence
NCT00396669

Unknown status

A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.

Conditions: Tobacco Use Disorder
NCT00953745

Completed

Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression

Conditions: Major Depressive Disorder
NCT02061722

Completed

[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET.

Conditions: Huntington's Disease
NCT00480246

Completed

A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer

Conditions: Healthy
NCT00846339

Completed

PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration

Conditions: Smoking
NCT00024960

Completed

Dopamine Function in Developmental Stuttering

Conditions: Developmental Stuttering
NCT03326245

Recruiting

Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI

Conditions: Normal Physiology
NCT02148783

Terminated

Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI

Conditions: Traumatic Brain Injury
NCT00716755

Completed

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Delusional Disorder; Psychotic Disorder
NCT02333487

Completed

Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700

Conditions: Schizophrenia
NCT02225106

Completed

Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI

Conditions: Cognition Disorder; Attention Deficit Disorder; Traumatic Brain Injury
NCT00050219

Completed

Role of Dopamine in Response to Alcohol

Conditions: Alcohol Consumption